Active	Status	Sponsor type	Region	Phase	Filter
3 Active 0 Inactive 3 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other Show only owner-sponsored trials	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes: « April » « 2025 » M T W T F S S 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4   - « April » « 2025 » M T W T F S S 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4   Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
RCT1100 / ReCode Therap
NCT05737485: Study Evaluating the Safety and Tolerability of RCT1100 in Healthy and PCD Subjects	Active, not recruiting	1	9	Europe, US, RoW	RCT1100	ReCode Therapeutics	Primary Ciliary Dyskinesia	07/24	01/25
NCT06600425: A Study to Assess the Safety, Tolerability, Ciliary Rescue, and Pharmacodynamics of RCT1100 in Adults with PCD	Recruiting	1	10	Europe	RCT1100	ReCode Therapeutics	Primary Ciliary Dyskinesia	06/25	09/25
NCT06633757: Study of Inhaled RCT1100 in Adults With PCD Caused by Pathogenic Mutations in the DNAI1 Gene to Measure Mucociliary Clearance	Recruiting	1	12	Europe, US	RCT1100	ReCode Therapeutics	Primary Ciliary Dyskinesia (PCD)	07/25	12/25

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
RCT1100 / ReCode Therap
NCT05737485: Study Evaluating the Safety and Tolerability of RCT1100 in Healthy and PCD Subjects	Active, not recruiting	1	9	Europe, US, RoW	RCT1100	ReCode Therapeutics	Primary Ciliary Dyskinesia	07/24	01/25
NCT06600425: A Study to Assess the Safety, Tolerability, Ciliary Rescue, and Pharmacodynamics of RCT1100 in Adults with PCD	Recruiting	1	10	Europe	RCT1100	ReCode Therapeutics	Primary Ciliary Dyskinesia	06/25	09/25
NCT06633757: Study of Inhaled RCT1100 in Adults With PCD Caused by Pathogenic Mutations in the DNAI1 Gene to Measure Mucociliary Clearance	Recruiting	1	12	Europe, US	RCT1100	ReCode Therapeutics	Primary Ciliary Dyskinesia (PCD)	07/25	12/25